Close

UPDATE: RBC Capital Assumes ZoomInfo Technologies (ZI) at Outperform

Go back to UPDATE: RBC Capital Assumes ZoomInfo Technologies (ZI) at Outperform

ZoomInfo (ZI) Explodes on Strong Q2 Results and Guidance, Analysts Bulled Up with 10 PT Hikes

August 3, 2021 9:33 AM EDT

Shares of ZoomInfo Technologies (NASDAQ: ZI) are up about 12% in todays trading session after the company delivered better-than-expected Q2 results. At least ten Wall Street analysts raised their price target on the stock following the print.

The company recorded earnings of $0.05 per share, while adjusted EPS came in at $0.14 per share, ahead of analyst estimates of $0.12 per share. Revenue for the quarter came in at $174 million to again top the $162.4 million consensus from the Street.

"ZoomInfo delivered another record quarter, including the highest levels ever for both retention activity and customer... More

ZoomInfo Technologies (ZI) PT Raised to $75 at BofA Securities

August 3, 2021 8:16 AM EDT

BofA Securities analyst Brad Sills raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $75.00 (from $70.00) while maintaining a Buy rating.

... More

ZoomInfo Technologies (ZI) PT Raised to $66 at Barclays

August 3, 2021 4:16 AM EDT

Barclays analyst Raimo Lenschow raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $66.00 (from $59.00) while maintaining a Equalweight rating.... More

After-Hours Stock Movers 08/02: (TBIO) (PCSA) (SEDG) Higher; (RNA) (ADUS) (SANM) Lower (more...)

August 2, 2021 5:50 PM EDT

After-Hours Stock Movers:

Translate Bio (NASDAQ: TBIO) 27.8% HIGHER; Sanofi (NASDAQ: SNY) made an offer to acquire Translate Bio (NASDAQ: TBIO)

Processa Pharmaceuticals (NASDAQ: PCSA) 23% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $20.00.

SolarEdge Technologies (NASDAQ: SEDG) 11% HIGHER; reported Q2 EPS of $1.28, $0.16 better than the analyst estimate of $1.12. Revenue for the quarter... More

ZoomInfo Technologies Inc. (ZI) Tops Q2 EPS by 2c, Raises Guidance

August 2, 2021 4:10 PM EDT

ZoomInfo Technologies Inc. (NASDAQ: ZI) reported Q2 EPS of $0.14, $0.02 better than the analyst estimate of $0.12. Revenue for the quarter came in at $174 million versus the consensus estimate of $162.34 million.

GUIDANCE:

ZoomInfo Technologies Inc. sees Q3 2021 EPS of $0.11-$0.12, versus the consensus... More